CONTROL BIONICS ORD
Control Bionics Integrates Apple Brain–Computer Interface to Enhance Accessibility and Independence
Control Bionics (ASX: CBL) has implemented Apple’s new Brain–Computer Interface protocol across its product range, a major step forward in assistive communication technology for people living with severe speech and physical impairments.
Control Bionics’ US sales and revenue growth fuels strong start to FY25
Australian medical device company Control Bionics (ASX: CBL) is expecting US revenue for the first six months of the 2025 financial year to increase by more than 15% on the previous corresponding period. The anticipated performance reflects increasing demand for the company’s artificial intelligence-based solutions, growing market penetration and a new Healthcare Common Procedure Coding […]
Control Bionics expands NeuroStrip presence into US and Japan with new agreements
Control Bionics (ASX: CBL) has expanded into the US sports performance and Japanese neurological rehabilitation markets with the first commercial agreements for its advanced NeuroStrip wireless wearable device. The strategic partnerships are with existing customers and will leverage the technology to drive better sports performance and patient outcomes, providing platforms for expansion into other regions. […]
Control Bionics gains official US approval for NeuroNode as reimbursable medical device
Control Bionics (ASX: CBL) has announced that the US Centers for Medicare & Medicaid Services (CMS) have approved a new healthcare common procedure coding system (HCPCS) that identifies the NeuroNode wireless and wearable sensor as a reimbursable medical device. NeuroNode has been created for patients with degenerative neurological diseases, spinal cord injuries, cerebral palsy and […]